NEUP

NEUPHORIA THERAPEUTICS INC

NEUP·64136E102·US·Common Stock·Healthcare - Biotechnology-Activist

NEUP (NEUPHORIA THERAPEUTICS INC) is held by 8 institutional investors as of Q1 2026. Largest holders: BALYASNY ASSET MANAGEMENT L.P. ($578,685), GEODE CAPITAL MANAGEMENT, LLC ($211,668), CITADEL ADVISORS LLC ($78,677). Net institutional sentiment: Mixed.

8
Holders
Avg rating(3 Elite)
$925,233
Total Value
67% (11)
Fund Consensus
6 buying - 3 selling
NEUPSmart Money Verdict
View all
Held by 8 funds
3 elite
Who's Trading
ActivistBABaselake Partners, LP4.1%Feb 6, 2026
ActivistLYLynx1 Capital Management LP16.3%Dec 29, 2025
ActivistCOCoastlands Capital LP5.1%Nov 5, 2025
ActivistSHShay Capital LLC7.3%Oct 31, 2025
InsiderLLLynx1 Capital Management LPBuy $3.3MOct 21, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
142,183$578,6850.0%-18.62%
34
Increased
52,007(+200.6%)$211,6680.0%-42.65%
25
New
19,331$78,6770.0%-18.62%
33
Increased
11,222(+0.1%)$45,6700.0%-5.11%
20
Increased
2,316(+40.2%)$9,4260.0%-63.53%
15
Unchanged
202$8220.0%-4.72%
0
Unchanged
58$2360.0%-4.82%
0
New
12,033$490.0%-18.62%
15
Exited
0(-100.0%)$64,3960.0%-61.86%
0
Exited
0(-100.0%)$700.0%-60.95%
0
Exited
0(-100.0%)$46,5910.0%+16.62%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used